|
Date
|
Time
|
Title
|
Speaker
|
Sponsor
|
|
10th March
|
01:00 – 01:15
|
Advances in the Management of Relapsed Multiple Myeloma
|
Dr. Halima El Omri
NCCCR, HMC, Qatar
|
Sanofi
|
|
10th March
|
03:25 – 03:50
|
Recent Updates in Relapsed Refractory Multiple Myeloma Management
|
Prof. María Victoria Mateos
University Hospital of Salamanca, Spain
|
Janssen
|
|
11th March
|
08:00 – 08:20
|
New Innovative Approaches in GvHD Management
|
Dr. Dennis Kim
Princess Margaret Cancer Centre, UHN, Canada
|
Novartis
|
|
11th March
|
01:25 – 01:50
|
The Art of Choosing BTKi for CLL Patients
|
Dr. Talha Munir
Leeds Teaching Hospitals NHS Trust, United Kingdom
|
AstraZeneca
|
|
11th March
|
04:00 – 04:15
|
Changing Treatment Paradigm: A New Dawn in DLBCL Treatment
|
Prof. Andrew Davies
University Hospital Southampton NHS Foundation Trust, United Kingdom
|
Roche
|
